A detailed history of American Portfolios Advisors transactions in Qiagen N.V. stock. As of the latest transaction made, American Portfolios Advisors holds 117 shares of QGEN stock, worth $5,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Holding current value
$5,272
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$40.9 - $50.42 $4,785 - $5,899
117 New
117 $4.93 Million
Q1 2022

Mar 21, 2023

BUY
$42.23 - $54.3 $4,771 - $6,135
113 Added 96.58%
230 $11.4 Million
Q4 2021

Mar 21, 2023

BUY
$50.62 - $56.47 $72,032 - $80,356
1,423 Added 1216.24%
1,540 $85.5 Million
Q3 2021

Mar 22, 2023

BUY
$46.55 - $56.83 $63,866 - $77,970
1,372 Added 1172.65%
1,489 $77.3 Million
Q2 2021

Mar 22, 2023

BUY
$46.28 - $52.75 $63,496 - $72,373
1,372 Added 1172.65%
1,489 $72 Million
Q1 2021

Mar 22, 2023

BUY
$46.25 - $56.02 $68,080 - $82,461
1,472 Added 1258.12%
1,589 $77.1 Million
Q4 2020

Mar 22, 2023

BUY
$46.09 - $54.74 $74,757 - $88,788
1,622 Added 1386.32%
1,739 $91.9 Million
Q3 2020

Mar 22, 2023

SELL
$42.51 - $52.42 $1,105 - $1,362
-26 Reduced 22.22%
91 $4.73 Million
Q2 2020

Mar 24, 2023

SELL
$39.49 - $44.36 $5,923 - $6,654
-150 Reduced 62.24%
91 $3.92 Million
Q1 2020

Mar 24, 2023

BUY
$33.17 - $41.6 $4,113 - $5,158
124 Added 105.98%
241 $9.68 Million
Q4 2019

Mar 24, 2023

BUY
$25.41 - $43.1 $3,481 - $5,904
137 Added 117.09%
254 $8.59 Million
Q3 2019

Mar 24, 2023

BUY
$32.73 - $40.81 $2,978 - $3,713
91 Added 165.45%
146 $4.78 Million
Q2 2019

Mar 24, 2023

SELL
$35.73 - $41.39 $2,215 - $2,566
-62 Reduced 52.99%
55 $2.24 Million
Q1 2019

Mar 24, 2023

SELL
$33.78 - $40.68 $3,546 - $4,271
-105 Reduced 89.74%
12 $487,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.3B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.